A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Clinical trial NCT07421414 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07421414
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2026-04-19
Primary completion: 2026-06-17
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.